TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 80 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2014. The put-call ratio across all filers is 5.00 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $69,000 | +885.7% | 120 | +100.0% | 0.00% | -50.0% |
| Q3 2016 | $7,000 | -22.2% | 60 | 0.0% | 0.00% | -33.3% |
| Q2 2016 | $9,000 | -76.3% | 60 | -76.9% | 0.00% | -76.9% |
| Q1 2016 | $38,000 | -11.6% | 260 | -7.1% | 0.01% | -18.8% |
| Q4 2015 | $43,000 | -88.3% | 280 | -89.1% | 0.02% | -87.2% |
| Q3 2015 | $369,000 | -10.9% | 2,580 | -10.4% | 0.12% | 0.0% |
| Q2 2015 | $414,000 | +9.5% | 2,880 | +7.5% | 0.12% | +28.9% |
| Q1 2015 | $378,000 | +29.0% | 2,680 | +35.4% | 0.10% | +27.6% |
| Q4 2014 | $293,000 | -12.5% | 1,980 | -9.2% | 0.08% | -28.3% |
| Q3 2014 | $335,000 | -14.1% | 2,180 | -21.6% | 0.11% | +19.1% |
| Q2 2014 | $390,000 | +14.0% | 2,780 | -9.7% | 0.09% | -7.3% |
| Q1 2014 | $342,000 | +4.9% | 3,080 | -6.7% | 0.10% | +1.1% |
| Q4 2013 | $326,000 | +10.1% | 3,300 | -15.4% | 0.10% | +8.0% |
| Q3 2013 | $296,000 | – | 3,900 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISZO CAPITAL MANAGEMENT LP | 582,409 | $90,011,000 | 60.33% |
| GUARDIAN POINT CAPITAL, LP | 70,000 | $10,819,000 | 10.19% |
| Think Investments LP | 186,373 | $28,804,000 | 8.16% |
| Greywolf Capital Management LP | 277,936 | $42,955,000 | 7.45% |
| Valentine Capital Asset Management, Inc. | 28,431 | $4,394,000 | 4.91% |
| FORT, L.P. | 63,675 | $9,841,000 | 4.69% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 527,266 | $81,489,000 | 3.63% |
| RPG Investment Advisory, LLC | 60,910 | $9,413,000 | 3.52% |
| Kerrisdale Advisers, LLC | 81,996 | $12,672,000 | 3.24% |
| Strategic Global Advisors, LLC | 48,154 | $7,442,000 | 3.17% |